{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:04:33Z","timestamp":1793887473562,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00432-023-04829-5","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:02:44Z","timestamp":1683896564000},"page":"9085-9104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the \u03b2-catenin signaling pathway"],"prefix":"10.1007","volume":"149","author":[{"given":"Angela","family":"Samy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0349-7262","authenticated-orcid":false,"given":"Mohamed Ali","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnanasekar","family":"Munirathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"4829_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cbi.2013.09.018","volume":"206","author":"C Bincoletto","year":"2013","unstructured":"Bincoletto C, Bechara A, Pereira GJ, Santos CP, Antunes F, Peixoto da-Silva J, Muler M, Gigli RD, Monteforte PT, Hirata H, Jurkiewicz A, Smaili SS (2013) Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies. Chem Biol Interact 206:279\u2013288","journal-title":"Chem Biol Interact"},{"key":"4829_CR2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4161\/auto.28390","volume":"10","author":"M Boyer-Guittaut","year":"2014","unstructured":"Boyer-Guittaut M, Poillet L, Liang Q, Bole-Richard E, Ouyang X, Benavides GA, Chakrama FZ, Fraichard A, Darley-Usmar VM, Despouy G, Jouvenot M, Delage-Mourroux R, Zhang J (2014) The role of GABARAPL1\/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells. Autophagy 10:986\u20131003","journal-title":"Autophagy"},{"key":"4829_CR3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.freeradbiomed.2019.08.025","volume":"143","author":"S Chinnapaka","year":"2019","unstructured":"Chinnapaka S, Zheng G, Chen A, Munirathinam G (2019) Nitro aspirin (NCX4040) induces apoptosis in PC3 metastatic prostate cancer cells via hydrogen peroxide (H2O2)-mediated oxidative stress. Free Radic Biol Med 143:494\u2013509","journal-title":"Free Radic Biol Med"},{"key":"4829_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.fct.2018.02.018","volume":"115","author":"S Dasari","year":"2018","unstructured":"Dasari S, Alpa Samy A, Kajdacsy-Balla M, Bosland C, Munirathinam G (2018a) Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling. Food Chem Toxicol 115:218\u2013227","journal-title":"Food Chem Toxicol"},{"key":"4829_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2018.03.029","volume":"828","author":"S Dasari","year":"2018","unstructured":"Dasari S, Alpa Samy P, Narvekar VS, Dontaraju R, Dasari AK, Munirathinam G (2018b) Polygodial analog induces apoptosis in LNCaP prostate cancer cells. Eur J Pharmacol 828:154\u2013162","journal-title":"Eur J Pharmacol"},{"key":"4829_CR6","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/ptr.6687","volume":"34","author":"S Dasari","year":"2020","unstructured":"Dasari S, Bakthavachalam V, Chinnapaka S, Venkatesan R, Samy A, Munirathinam G (2020) Neferine, an alkaloid from lotus seed embryo targets HeLa and SiHa cervical cancer cells via pro-oxidant anticancer mechanism. Phytother Res 34:2366\u20132384","journal-title":"Phytother Res"},{"key":"4829_CR7","doi-asserted-by":"crossref","first-page":"T11","DOI":"10.1530\/ERC-21-0116","volume":"28","author":"AH Davies","year":"2021","unstructured":"Davies AH, Zoubeidi A (2021) Targeting androgen receptor signaling: a historical perspective. Endocr Relat Cancer 28:T11\u2013T18","journal-title":"Endocr Relat Cancer"},{"key":"4829_CR8","first-page":"200","volume":"34","author":"MC de Almagro","year":"2012","unstructured":"de Almagro MC, Vucic D (2012) The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol 34:200\u2013211","journal-title":"Exp Oncol"},{"key":"4829_CR9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/1078-0432.CCR-16-2172","volume":"23","author":"A Derakhshan","year":"2017","unstructured":"Derakhshan A, Chen Z, Van Waes C (2017) Therapeutic small molecules target inhibitor of apoptosis proteins in cancers with deregulation of extrinsic and intrinsic cell death pathways. Clin Cancer Res 23:1379\u20131387","journal-title":"Clin Cancer Res"},{"key":"4829_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajur.2018.11.005","volume":"6","author":"L Dong","year":"2019","unstructured":"Dong L, Zieren RC, Xue W, de Reijke TM, Pienta KJ (2019) Metastatic prostate cancer remains incurable, why? Asian J Urol 6:26\u201341","journal-title":"Asian J Urol"},{"key":"4829_CR11","volume":"188","author":"F Gao","year":"2020","unstructured":"Gao F, Sun Z, Kong F, Xiao J (2020) Artemisinin-derived hybrids and their anticancer activity. Eur J Med Chem 188:112044","journal-title":"Eur J Med Chem"},{"key":"4829_CR12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pdpdt.2017.10.026","volume":"21","author":"T Gheewala","year":"2018","unstructured":"Gheewala T, Skwor T, Munirathinam G (2018) Photodynamic therapy using pheophorbide and 670nm LEDs exhibits anti-cancer effects in-vitro in androgen dependent prostate cancer. Photodiagnosis Photodyn Ther 21:130\u2013137","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4829_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221:3\u201312","journal-title":"J Pathol"},{"key":"4829_CR14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645\u2013659","journal-title":"Cell"},{"key":"4829_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"4829_CR16","first-page":"1427","volume":"42","author":"JR Heo","year":"2018","unstructured":"Heo JR, Kim SM, Hwang KA, Kang JH, Choi KC (2018) Resveratrol induced reactive oxygen species and endoplasmic reticulum stressmediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line. Int J Mol Med 42:1427\u20131435","journal-title":"Int J Mol Med"},{"key":"4829_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/neuros\/nyw026","volume":"80","author":"Y Iwadate","year":"2017","unstructured":"Iwadate Y, Suganami A, Tamura Y, Matsutani T, Hirono S, Shinozaki N, Hiwasa T, Takiguchi M, Saeki N (2017) The pluripotent stem-cell marker alkaline phosphatase is highly expressed in refractory glioblastoma with DNA hypomethylation. Neurosurgery 80:248\u2013256","journal-title":"Neurosurgery"},{"key":"4829_CR18","first-page":"317","volume":"8","author":"M Juarez","year":"2018","unstructured":"Juarez M, Schcolnik-Cabrera A, Duenas-Gonzalez A (2018) The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Am J Cancer Res 8:317\u2013331","journal-title":"Am J Cancer Res"},{"key":"4829_CR19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ab.2008.10.005","volume":"384","author":"J Kaur","year":"2009","unstructured":"Kaur J, Bachhawat AK (2009) A modified Western blot protocol for enhanced sensitivity in the detection of a membrane protein. Anal Biochem 384:348\u2013349","journal-title":"Anal Biochem"},{"key":"4829_CR20","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/elps.11501601175","volume":"16","author":"J Klose","year":"1995","unstructured":"Klose J, Kobalz U (1995) Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16:1034\u20131059","journal-title":"Electrophoresis"},{"key":"4829_CR21","doi-asserted-by":"crossref","first-page":"E7301","DOI":"10.1073\/pnas.1705441114","volume":"114","author":"M Kodama","year":"2017","unstructured":"Kodama M, Kodama T, Newberg JY, Katayama H, Kobayashi M, Hanash SM, Yoshihara K, Wei Z, Tien JC, Rangel R, Hashimoto K, Mabuchi S, Sawada K, Kimura T, Copeland NG, Jenkins NA (2017) In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer. Proc Natl Acad Sci U S A 114:E7301\u2013E7310","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4829_CR22","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.369","volume":"8","author":"P Kranz","year":"2017","unstructured":"Kranz P, Neumann F, Wolf A, Classen F, Pompsch M, Ocklenburg T, Baumann J, Janke K, Baumann M, Goepelt K, Riffkin H, Metzen E, Brockmeier U (2017) PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). Cell Death Dis 8:e2986","journal-title":"Cell Death Dis"},{"key":"4829_CR23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrurol.2012.116","volume":"9","author":"RM Kypta","year":"2012","unstructured":"Kypta RM, Waxman J (2012) Wnt\/beta-catenin signalling in prostate cancer. Nat Rev Urol 9:418\u2013428","journal-title":"Nat Rev Urol"},{"key":"4829_CR24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A (2017) Targeting autophagy in cancer. Nat Rev Cancer 17:528\u2013542","journal-title":"Nat Rev Cancer"},{"key":"4829_CR25","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.2147\/CMAR.S174237","volume":"10","author":"D Li","year":"2018","unstructured":"Li D, Lv H, Hao X, Hu B, Song Y (2018) Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis. Cancer Manag Res 10:3125\u20133139","journal-title":"Cancer Manag Res"},{"key":"4829_CR26","volume":"11","author":"YQ Li","year":"2021","unstructured":"Li YQ, Zheng Z, Liu QX, Lu X, Zhou D, Zhang J, Zheng H, Dai JG (2021) Repositioning of antiparasitic drugs for tumor treatment. Front Oncol 11:670804","journal-title":"Front Oncol"},{"key":"4829_CR27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.15252\/emmm.201404084","volume":"6","author":"A Melotti","year":"2014","unstructured":"Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz i Altaba A (2014) The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. EMBO Mol Med 6:1263\u20131278","journal-title":"EMBO Mol Med"},{"key":"4829_CR28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/cells8080793","volume":"8","author":"L Milkovic","year":"2019","unstructured":"Milkovic L, Cipak Gasparovic A, Cindric M, Mouthuy PA, Zarkovic N (2019) Short overview of ros as cell function regulators and their implications in therapy concepts. Cells 8:793","journal-title":"Cells"},{"key":"4829_CR29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/jat.2782","volume":"33","author":"G Molinari","year":"2013","unstructured":"Molinari G, Kujawski M, Scuto A, Soloneski S, Larramendy ML (2013) DNA damage kinetics and apoptosis in ivermectin-treated Chinese hamster ovary cells. J Appl Toxicol 33:1260\u20131267","journal-title":"J Appl Toxicol"},{"key":"4829_CR30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-019-0474-7","volume":"27","author":"JM Mulcahy Levy","year":"2020","unstructured":"Mulcahy Levy JM, Thorburn A (2020) Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ 27:843\u2013857","journal-title":"Cell Death Differ"},{"key":"4829_CR31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"V Murillo-Garzon","year":"2017","unstructured":"Murillo-Garzon V, Kypta R (2017) WNT signalling in prostate cancer. Nat Rev Urol 14:683\u2013696","journal-title":"Nat Rev Urol"},{"key":"4829_CR32","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","volume":"1833","author":"V Nikoletopoulou","year":"2013","unstructured":"Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N (2013) Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta 1833:3448\u20133459","journal-title":"Biochim Biophys Acta"},{"key":"4829_CR33","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/15548627.2015.1091141","volume":"11","author":"HO Rashid","year":"2015","unstructured":"Rashid HO, Yadav RK, Kim HR, Chae HJ (2015) ER stress: autophagy induction, inhibition and selection. Autophagy 11:1956\u20131977","journal-title":"Autophagy"},{"key":"4829_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10:63\u201389","journal-title":"World J Oncol"},{"key":"4829_CR35","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115071","volume":"401","author":"A Samy","year":"2020","unstructured":"Samy A, Bakthavachalam V, Vudutha M, Vinjamuri S, Chinnapaka S, Munirathinam G (2020) Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis. Toxicol Appl Pharmacol 401:115071","journal-title":"Toxicol Appl Pharmacol"},{"key":"4829_CR36","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.18632\/oncotarget.3368","volume":"6","author":"FR Santer","year":"2015","unstructured":"Santer FR, Erb HH, Oh SJ, Handle F, Feiersinger GE, Luef B, Bu H, Schafer G, Ploner C, Egger M, Rane JK, Maitland NJ, Klocker H, Eder IE, Culig Z (2015) Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy. Oncotarget 6:6105\u20136122","journal-title":"Oncotarget"},{"key":"4829_CR37","doi-asserted-by":"crossref","first-page":"33972","DOI":"10.18632\/oncotarget.15687","volume":"8","author":"S Shang","year":"2017","unstructured":"Shang S, Hua F, Hu ZW (2017) The regulation of beta-catenin activity and function in cancer: therapeutic opportunities. Oncotarget 8:33972\u201333989","journal-title":"Oncotarget"},{"key":"4829_CR38","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0020-7519(96)00122-1","volume":"26","author":"WL Shoop","year":"1996","unstructured":"Shoop WL, DeMontigny P, Fink DW, Williams JB, Egerton JR, Mrozik H, Fisher MH, Skelly BJ, Turner MJ (1996) Efficacy in sheep and pharmacokinetics in cattle that led to the selection of eprinomectin as a topical endectocide for cattle. Int J Parasitol 26:1227\u20131235","journal-title":"Int J Parasitol"},{"key":"4829_CR39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"4829_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-108-6_1","volume":"740","author":"MJ Stoddart","year":"2011","unstructured":"Stoddart MJ (2011) Cell viability assays: introduction. Methods Mol Biol 740:1\u20136","journal-title":"Methods Mol Biol"},{"key":"4829_CR41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo MY, Rathkopf DE, Kantoff P (2019) Treatment of advanced prostate cancer. Annu Rev Med 70:479\u2013499","journal-title":"Annu Rev Med"},{"key":"4829_CR42","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K (2012) The many faces and functions of beta-catenin. EMBO J 31:2714\u20132736","journal-title":"EMBO J"},{"key":"4829_CR43","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10552-021-01484-4","volume":"32","author":"KL Wallace","year":"2021","unstructured":"Wallace KL, Landsteiner A, Bunner SH, Engel-Nitz NM, Luckenbaugh AN (2021) Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States. Cancer Causes Control 32:1365\u20131374","journal-title":"Cancer Causes Control"},{"key":"4829_CR44","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","volume":"37","author":"YK Wong","year":"2017","unstructured":"Wong YK, Xu C, Kalesh KA, He Y, Lin Q, Wong WSF, Shen HM, Wang J (2017) Artemisinin as an anticancer drug: recent advances in target profiling and mechanisms of action. Med Res Rev 37:1492\u20131517","journal-title":"Med Res Rev"},{"key":"4829_CR45","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","volume":"44","author":"Z Yu","year":"2012","unstructured":"Yu Z, Pestell TG, Lisanti MP, Pestell RG (2012) Cancer stem cells. Int J Biochem Cell Biol 44:2144\u20132151","journal-title":"Int J Biochem Cell Biol"},{"key":"4829_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X (2020) Targeting the Wnt\/beta-catenin signaling pathway in cancer. J Hematol Oncol 13:165","journal-title":"J Hematol Oncol"},{"key":"4829_CR47","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/pros.22627","volume":"73","author":"S Zhang","year":"2013","unstructured":"Zhang S, Wang Y, Chen Z, Kim S, Iqbal S, Chi A, Ritenour C, Wang YA, Kucuk O, Wu D (2013) Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. Prostate 73:1681\u20131689","journal-title":"Prostate"},{"key":"4829_CR48","volume":"156","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang G, Zhai W, Zhao Z, Wang S, Yi J (2020) Inhibition of TMEM16A Ca(2+)-activated Cl(\u2212) channels by avermectins is essential for their anticancer effects. Pharmacol Res 156:104763","journal-title":"Pharmacol Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04829-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T20:20:26Z","timestamp":1702412426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04829-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4829"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04829-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}